Cargando…

Assessing the impact of open-label designs in patient-reported outcomes: investigation in oncology clinical trials

BACKGROUND: Knowledge of treatment assignment may affect patient-reported outcomes (PROs), which is of concern in oncology, where open-label trials are common. This study measured the magnitude of open-label bias by comparing PROs for similar patient groups in oncology trials with different degrees...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lord-Bessen, Jennifer, Signorovitch, James, Yang, Min, Georgieva, Mihaela, Roydhouse, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023242/ https://www.ncbi.nlm.nih.gov/pubmed/36661326 http://dx.doi.org/10.1093/jncics/pkad002

Ejemplares similares

Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials
por: Mouillet, Guillaume, et al.
Publicado: (2020)

Attitudes towards open‐label versus placebo‐control designs in oncology randomized trials: A survey of medical oncologists
por: Kushnir, Igal, et al.
Publicado: (2022)

An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial
por: Koga, Tomohiro, et al.
Publicado: (2020)

Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials
por: Kim, Yeonju, et al.
Publicado: (2023)

Rationale, design, and methods of a randomized, controlled, open-label clinical trial with open-label extension to investigate the safety of vosoritide in infants, and young children with achondroplasia at risk of requiring cervicomedullary decompression surgery
por: Savarirayan, Ravi, et al.
Publicado: (2021)

An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease: Study protocol for an investigator-initiated, multicenter, open-label trial (SPIRIT compliant)
por: Koga, Tomohiro, et al.
Publicado: (2020)

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials
por: Kahan, Brennan C, et al.
Publicado: (2014)

A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma
por: Yurttas, Can, et al.
Publicado: (2021)

Can we reduce bias in open-label trials when blinded outcome assessment is not possible? An example from the trigger trial
por: Kahan, Brennan, et al.
Publicado: (2015)

P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY
por: van de Donk, N. W., et al.
Publicado: (2022)

Completion rate and impact on physician–patient relationship of video consultations in medical oncology: a randomised controlled open-label trial
por: Walle, Thomas, et al.
Publicado: (2020)

Blinding of outcome assessors and its association with outcome in a randomized open-label stroke trial
por: van der Ende, Nadinda AM, et al.
Publicado: (2022)

International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials
por: Brady, Keri J. S., et al.
Publicado: (2023)

Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation
por: Yamamoto, Atsushi, et al.
Publicado: (2022)

Ethosuximide for Essential Tremor: An Open-Label Trial
por: Gironell, Alexandre, et al.
Publicado: (2016)

The frequency of assessment of progression in randomized oncology clinical trials
por: Haslam, Alyson, et al.
Publicado: (2021)

An Open-Label Trial Study of Quality-of-Life Assessment in Irritable Bowel Syndrome and Their Treatment
por: Alexandru, Bogdana Ariana, et al.
Publicado: (2022)

Electrophysiological Biomarkers Predict Clinical Improvement in an Open‐Label Trial Assessing Efficacy of Autologous Umbilical Cord Blood for Treatment of Autism
por: Murias, Michael, et al.
Publicado: (2018)

Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations
por: Schwartzberg, Barbara, et al.
Publicado: (2018)

Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes
por: Uno, Hajime, et al.
Publicado: (2019)

“Sharing in hopes and worries”—a qualitative analysis of the delivery of compassionate care in palliative care and oncology at end of life
por: Bessen, Sarah, et al.
Publicado: (2019)

Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study
por: Gafos, Mitzy, et al.
Publicado: (2017)

Basic Design Considerations for Clinical Trials in Oncology
por: Piantadosi, Steven, et al.
Publicado: (1992)

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments
por: Trapani, Dario, et al.
Publicado: (2022)

Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Efficacious Web-Based Psychotherapy to Address Depression and Anxiety Among Patients Receiving Oncological and Palliative Care: an Open-Label Randomised Controlled Trial
por: Alavi, N., et al.
Publicado: (2023)

An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19
por: Bengtson, Charles D., et al.
Publicado: (2021)

An open-label trial of alsuma auto-injector for migraine
por: Ramos, E, et al.
Publicado: (2013)

Open-label, add-on trial of cetirizine for neuromyelitis optica
por: Katz Sand, Ilana, et al.
Publicado: (2018)

Bumetanide for autism: Open‐label trial in six children
por: Fernell, Elisabeth, et al.
Publicado: (2021)

Effects of practicing yoga on alexisomia: an open-label trial
por: Oka, Takakazu, et al.
Publicado: (2022)

Master protocol trials in oncology: Review and new trial designs
por: Hirakawa, Akihiro, et al.
Publicado: (2018)

Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design
por: Quintero, Jorge E, et al.
Publicado: (2022)

Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial
por: Ortega, Hector, et al.
Publicado: (2019)

Shunting outcomes in communicating hydrocephalus: protocol for a multicentre, open-label, randomised controlled trial
por: Sun, Tong, et al.
Publicado: (2021)

Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial
por: van der Ende, Nadinda A.M., et al.
Publicado: (2021)

Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
por: Koh, Jung-Min, et al.
Publicado: (2016)

Labeling for Big Data in radiation oncology: The Radiation Oncology Structures ontology
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2018)

AB145. The investigation of the clinical safety and oncologic outcomes between retroperitoneoscopic and open radical nephrectomy (tumor size >7 cm)
por: Li, Zeliang, et al.
Publicado: (2016)

Clinical Trial Design and Drug Approval in Oncology: A Primer for the Advanced Practitioner in Oncology
por: Kurtin, Sandra E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ia30id9dnos812kgkp11f4o6bh